Forever young: the firms keeping people active

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

HOW AI IS SUPERCHARGING THE SECTOR

CITY

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

Last year, Henderson European Focus Trust and Henderson EuroTrust merged to form Henderson European Trust (LSE: HET), with £680m of assets (after significant cash exits) and a well-regarded management

How old do you want to be when you die? Grim, I know. But seriously, think about it. More importantly, what kind of life do you want to be living right up until that moment? I ask because I have a pla